VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RAYRaytech Holding Limited Ordinary Shares
$2.64$8M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRAYFinancials

Raytech Holding Limited Ordinary Shares (RAY) Financials

5Y historyFree accessUpdated daily

Revenue growth remains highly volatile, swinging from a 78.8% surge in 2024Q2 to a 13.5% contraction in 2026Q2, while gross margins have fluctuated between 18.2% and 26.4% over the last ten quarters.

RAY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMMar'25Mar'24Mar'23Mar'22Mar'21
Sales/Revenue150.12M78.74M66.97M45.52M45.11M31.86M
Revenue Growth %-17.57%47.13%0.91%41.58%-
Cost of Goods Sold116.29M60.93M52.07M4.36M4.24M23.95M
COGS % of Revenue-77.38%77.74%9.57%9.41%75.19%
Gross Profit33.83M17.81M14.9M1.45M1.55M7.91M
Gross Margin %22.54%22.62%22.26%3.18%3.44%24.81%
Gross Profit Growth %-19.48%928.89%-6.55%-80.39%-
Operating Expenses17.11M10.16M3.55M4.28M1.38M1.19M
OpEx % of Revenue-12.9%5.29%9.4%3.06%3.72%
Selling, General & Admin17.11M10.16M3.46M4.16M1.34M1.17M
SG&A % of Revenue-12.9%5.16%9.14%2.98%3.68%
Research & Development000000
R&D % of Revenue------
Other Operating Expenses3.69K090.34K116.5K37.53K12.18K
Operating Income16.72M7.65M11.36M7.19M10.72M6.72M
Operating Margin %11.14%9.71%16.96%15.81%23.78%21.09%
Operating Income Growth %--32.67%57.9%-32.92%59.6%-
EBITDA17.89M7.65M11.36M7.21M10.73M6.73M
EBITDA Margin %11.92%9.72%16.97%15.84%23.79%21.13%
EBITDA Growth %--32.65%57.64%-32.81%59.38%-
D&A (Non-Cash Add-back)6.81K4.87K4.87K14.86K4.82K12.18K
EBIT17.89M10.52M11.36M7.19M10.72M6.72M
Net Interest Income5.32M3.16M1.41M136.2K-1.35K1.3K
Interest Income5.32M3.16M1.42M143.35K3271.3K
Interest Expense002.03K7.15K1.68K0
Other Income/Expense4.84M2.88M1.39M279.65K455.94K2.65K
Pretax Income21.56M10.52M12.75M7.47M11.18M6.72M
Pretax Margin %14.36%13.37%19.04%16.42%24.79%21.1%
Income Tax5.04M2.26M2.82M1.18M1.74M1.1M
Effective Tax Rate %23.39%21.44%22.09%15.8%15.56%16.34%
Net Income16.52M8.27M9.94M6.29M9.44M5.62M
Net Margin %11%10.5%14.84%13.82%20.93%17.65%
Net Income Growth %--16.79%57.91%-33.34%67.86%-
Net Income (Continuing)16.52M8.27M9.94M6.29M9.44M5.62M
Discontinued Operations000000
Minority Interest000000
EPS (Diluted)5.863.003.882.253.382.00
EPS Growth %--22.68%72.44%-33.43%69%-
EPS (Basic)-3.003.882.253.382.00
Diluted Shares Outstanding2.82M2.75M2.56M2.8M2.8M2.8M
Basic Shares Outstanding2.82M2.75M2.56M2.8M2.8M2.8M
Dividend Payout Ratio----16.5%-

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Capital allocation inefficiency

Volatile Revenue Growth Patterns Observed

According to the provided income statement data, Raytech's revenue trajectory exhibits significant volatility, swinging from a 78.8% surge in 2024Q2 to a 13.5% contraction by 2026Q2, suggesting that the company's top-line performance remains highly sensitive to the timing of specific purchase orders from international brand owners.

The erratic revenue growth suggests that Raytech lacks a recurring revenue base, leaving it vulnerable to the cyclical inventory cycles of its clients. Investors should monitor whether this inconsistency reflects a lack of long-term contract stability or merely the lumpy nature of ODM project-based manufacturing.

Margin Compression Amid Competitive Pressures

As reported in financial statements, Raytech's gross margin has fluctuated between 18.2% and 26.4% over the last ten quarters, indicating that the company faces persistent challenges in maintaining pricing power while navigating the competitive landscape of high-precision personal care electronics manufacturing.

The compression of gross margins during periods of higher revenue suggests that Raytech may be sacrificing pricing to secure volume, which is a common trait in commoditized ODM markets. This trend warrants further investigation into whether the company can achieve economies of scale or if it remains a price-taker.

Non-Operating Income Distorts Earnings Quality

Based on the company's reported figures, the net margin of 10.50% frequently exceeds the operating margin of 9.71%, which implies that a meaningful portion of the bottom-line profitability is derived from non-operating sources, likely interest income generated by the company's substantial cash reserves.

This discrepancy suggests that the core manufacturing business is less profitable than the headline net income figures might imply to a casual observer. Analysts should strip out these non-operating gains to accurately assess the underlying operational health and efficiency of the manufacturing segment.

SG&A Efficiency Masks Operational Risks

Data from recent filings indicates that SG&A expenses have remained relatively contained, yet the lack of R&D investment, consistently reported at zero, suggests a potential long-term risk to the company's ability to innovate and maintain its niche competitive position in the personal care electronics market.

While the low SG&A profile supports current operating margins, the absence of R&D spending may indicate a reliance on legacy tooling rather than future-proofing the product portfolio. This strategy appears to prioritize short-term cost discipline over the long-term technical differentiation required to sustain an ODM moat.

RAY — Frequently Asked Questions

Quick answers to the most common questions about buying RAY stock.

What was Raytech Holding Limited Ordinary Shares's (RAY) revenue in 2025?

For fiscal year 2025, Raytech Holding Limited Ordinary Shares (RAY) reported total revenue of $78.7M. This represents a 147.2% increase compared to $31.9M in 2021.

Is Raytech Holding Limited Ordinary Shares (RAY) profitable?

Raytech Holding Limited Ordinary Shares (RAY) is profitable, generating $8.3M in net income for the fiscal year ending 2025 with a net profit margin of 10.5%.

What is Raytech Holding Limited Ordinary Shares's operating profit margin?

Raytech Holding Limited Ordinary Shares (RAY) reported an operating income of $7.6M, resulting in an operating profit margin of 9.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Raytech Holding Limited Ordinary Shares's gross profit and gross margin?

Raytech Holding Limited Ordinary Shares (RAY) generated $17.8M in gross profit for the year, representing a gross profit margin of 22.6%. This demonstrates the company's core pricing power and production efficiency.